Emerging roles of DMP1 in lung cancer

Cancer Research

Volumn 68, Issue 12, 2008, Pages 4487-4490

  Inoue, Kazushi ^a   Sugiyama, Takayuki ^a   Taneja, Pankaj ^a   Morgan, Rachel L ^a   Frazier, Donna P ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DENTIN MATRIX PROTEIN 1; DMP1 PROTEIN, HUMAN; DMP1 PROTEIN, MOUSE; PHOSPHOPROTEIN; RAS PROTEIN; SCLEROPROTEIN;

DNA SEQUENCE; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENOMICS; HUMAN; LUNG NON SMALL CELL CANCER; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; REVIEW; ANIMAL; LUNG TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; EXTRACELLULAR MATRIX PROTEINS; HUMANS; LUNG NEOPLASMS; PHOSPHOPROTEINS; RAS PROTEINS; SIGNAL TRANSDUCTION;

EID: 49649092472     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-6791     Document Type: Review

References (21)

1. Sun S, Schiller JH, Spinora M, Minna JD. New molecular targeted therapies for lung cancer. J Clin Invest 2007;117:2740-50.
2. Spira A, Ettinger DS. Multidisciplinary management of lung cancer. N Engl J Med 2004;350:379-92.
3. Meuwissen R, Berns A. Mouse models for human lung cancer. Genes Dev 2005;19:643-64.
4. Lowe S, Sherr CJ. Tumor suppression by Ink4a-Arf: progress and puzzles. Curr Opin Genet Dev 2003;13:77-83.
5. Sherr CJ. Divorcing ARF and p53: an unsettled case. Nat Rev Cancer 2006;6:663-73.
6. Johnson L, Mercer K, Greenbaum D, et al. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 2001;410:1111-6.
7. Mallakin A, Sugiyama T, Taneja P, et al. Mutually exclusive inactivation of DMP1 and ARF/p53 in lung cancer. Cancer Cell 2007;12:381-94.
8. Hirai H, Sherr CJ. Interaction of D-type cyclins with a novel myb-like transcription factor, DMP1. Mol Cell Biol 1996;16:6457-67.
9. Inoue K, Sherr CJ. Gene expression and cell cycle arrest mediated by transcription factor DMP1 is antagonized by D-type cyclins through a cyclin-dependent-kinase-independent mechanism. Mol Cell Biol 1998;18:1590-600.
10. Inoue K, Roussel MF, Sherr CJ. Induction of ARF tumor suppressor gene expression and cell cycle arrest by transcription factor DMP1. Proc Natl Acad Sci U S A 1999;96:3993-8.
11. Inoue K, Wen R, Rehg JE, et al. Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesis. Genes Dev 2000;14:1797-809.
12. Inoue K, Zindy F, Randle DH, Rehg JE, Sherr CJ. Dmp1 is haplo-insufficient for tumor suppression and modifies the frequencies of Arf and p53 mutations in Myc-induced lymphomas. Genes Dev 2001;15:2934-9.
13. Eischen CM , Weber JD, Roussel MF, Sherr CJ, Cleveland JL. Disruption of the ARF-Mdm2-53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev 1999;13:2658-69.
14. Quon KC, Berns A. Haplo-insufficiency? Let me count the ways. Genes Dev 2001;15:2917-21.
15. Sreeramaneni R, Chaudhry A, McMahon M, Sherr CJ, Inoue K. Ras-Raf-Arf signaling critically depends on Dmp1 transcription factor. Mol Cell Biol 2005;25:220-32.
16. Mallakin A, Taneja P, Matise LA, Willingham MC, Inoue K. Expression of Dmp1 in specific differentiated, nonproliferating cells and its repression by E2Fs. Oncogene 2006;25:7703-13.
17. Taneja P, Mallakin A, Matise LA, Frazier DP, Choudhary M, Inoue K. Repression of Dmp1 and Arf transcription by anthracyclins: critical roles of the NF-κB subunit p65. Oncogene 2007;26:7457-66.
18. Bodner SM, Naeve CW, Rakestraw KM, et al. Cloning and chromosomal localization of the gene encoding human cyclin D-binding Myb-like protein (hDMP1). Gene 1999;229:223-8.
19. Bieche I, Champeme MH, Matifas F, Hacene K, Callahan R, Lidereau R. Loss of heterozygosity on chromosome 7q and aggressive primary breast cancer. Lancet 1992;339:139-43.
20. Tschan MP, Fischer KM, Fung VS, et al. Alternative splicing of the human cyclin D-binding Myb-like protein (hDMP1) yields a truncated protein isoform that alters macrophage differentiation patterns. J Biol Chem 2003;278:42750-60.
21. Sanchez-Cespedes M, Reed AL, Buta M, et al. Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer. Oncogene 1999;18:5843-9.